Buy Madrigal Pharmaceuticals Stock | MDGL Stock Price & Latest News | Public
MDGL

Madrigal Pharmaceuticals

$0.00 (0.00%)Today

    About MDGL

    Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatiti...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -1.12
    -2.24
    -3.37
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$3.37

    Actual EPS
    Q3 2020

    Stats

    Market Cap$1,91B
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$127.25
    1 Year Low$56.82
    Open$121.60
    High$124.47
    Low$121.59

    Buy any stock with any amount of money.

    Download the App
    Download the app